Patents for C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273) |
---|
06/08/2005 | CN1205210C 9-azabicyclo (3,3,1) non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ACH receptors |
06/08/2005 | CN1205209C Method of preparing endonortropine by using 9-benzyl-nortropine-3-one-perchlorate as intermediate and salt thereof |
06/07/2005 | US6903117 Indole derivatives for the treatment of osteoporosis |
06/07/2005 | US6903085 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
06/01/2005 | EP1534703A2 Antagonists of melanin concentrating hormone receptor |
06/01/2005 | EP1534695A2 Tyrosine kinase inhibitors |
06/01/2005 | EP1534689A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof |
06/01/2005 | EP1534282A2 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
05/31/2005 | US6900227 Benzodioxole derivatives |
05/26/2005 | WO2005046586A2 M3 muscarinic acetylcholine receptor antagonists |
05/26/2005 | US20050113383 For therapy of allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
05/25/2005 | EP1532143A1 Methods for producing hydroxyalkyl tropane esters |
05/25/2005 | EP1532132A1 Novel benzodioxoles |
05/19/2005 | US20050107389 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
05/12/2005 | WO2005042533A2 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors |
05/12/2005 | WO2005042529A1 Improved aza-bridged-bicyclic amino acid derivatives as a4 integrin antagonists |
05/12/2005 | WO2005042528A1 Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same |
05/12/2005 | WO2005042527A1 Novel crystalline anhydride with anticholinergic effect |
05/12/2005 | WO2005042526A1 Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same |
05/12/2005 | WO2005021519A3 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases |
05/12/2005 | CA2544357A1 Tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same |
05/12/2005 | CA2544352A1 Crystalline anhydrate with anticholinergic effect |
05/12/2005 | CA2544348A1 Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same |
05/12/2005 | CA2543533A1 2-cyanopyrrolidinecarboxamide compound |
05/12/2005 | CA2543438A1 Improved aza-bridged-bicyclic amino acid derivatives as a4 integrin antagonists |
05/11/2005 | EP1337532B1 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit |
05/10/2005 | US6891042 An ester of 3-hydroxy-8-methyl-6,7-(amino-methylenedioxy)-8-azabicyclo(3.2.1)octane; intermediate to tiotropium bromide for example |
05/05/2005 | US20050096346 Process for preparing N-substituted 3-beta-aminonortropanes |
05/05/2005 | US20050096341 Novel tiotropium salts, process for the preparation and pharmaceutical compositions thereof |
05/04/2005 | EP1404673B1 Technical synthesis method for producing tropenol |
04/28/2005 | WO2005037831A1 METHOD FOR PRODUCING N-SUBSTITUTED 3β-AMINONORTROPANES |
04/28/2005 | WO2005037280A1 Muscarinic acetycholine receptor antagonists |
04/28/2005 | WO2005037224A2 Muscarinic acetylcholine receptor antagonists |
04/28/2005 | WO2005036961A2 N-substituted azacycles |
04/28/2005 | US20050090533 Treating schizophrenia by administering an N-(2-aminopyridin-5-yl)amino-phenylisobutyramide, e.g., N-[6-(2-acetylamino-ethylamino)-4-(2-chloro-phenyl)-pyridin-3-yl]-2-(3,5-bis-trifluoromethyl-phenyl)-N-methyl-isobutyramide |
04/28/2005 | CA2542636A1 Muscarinic acetylcholine receptor antagonists field of the invention |
04/27/2005 | EP1526134A2 Triazolyl tropane derivatives as ccr5 modulators |
04/27/2005 | EP1525201A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
04/27/2005 | CN1610680A Process for preparing scopine esters |
04/27/2005 | CN1610666A Benzamidine derivative |
04/20/2005 | EP1523778A2 Heteroatom-containing diamondoid transistors |
04/14/2005 | WO2004013120A8 Novel benzodioxoles |
04/14/2005 | US20050080095 Novel amides useful for treating pain |
04/14/2005 | US20050080067 Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
04/13/2005 | EP1521747A2 Receptor-type kinase modulators and methods of use |
04/07/2005 | WO2005030188A2 Phenyl-piperazine derivatives as modulators of muscarinic receptors |
04/07/2005 | WO2005009362A3 Muscarinic acetylcholine receptor antagonists |
04/07/2005 | CA2540186A1 Phenyl-piperazine derivatives as modulators of muscarinic receptors |
04/05/2005 | US6875449 Crystal structure |
03/31/2005 | WO2005028466A1 Benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors |
03/31/2005 | CA2539566A1 Benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors |
03/30/2005 | EP1518855A1 Diaminopyrimidinecarboxa mide derivative |
03/30/2005 | EP1518562A2 Dopamine transporter imaging agents |
03/30/2005 | EP1518561A2 Dopamine transporter imaging agents |
03/30/2005 | EP1517907A2 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity |
03/24/2005 | WO2004064789A3 Quaternary antimuscarinic compounds for the treatment of bladder diseases |
03/24/2005 | US20050065211 Ester derivatives |
03/22/2005 | US6869943 Sorbitol dehydrogenase inhibitors |
03/22/2005 | CA2330092C Benzimidazole compounds as orl1-receptor agonists |
03/17/2005 | WO2005023257A1 Novel process, salts, compositions and use |
03/17/2005 | US20050059712 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
03/16/2005 | EP1513838A1 Technical method for producing tropenol |
03/16/2005 | EP1513529A1 Triple monoamine reuptake inhibitors for the treatment of chronic pain |
03/15/2005 | US6867201 For therapy of abnormal cell growth, such as cancer, in mammals |
03/10/2005 | WO2005021539A1 Benzimidazolone compounds having 5-ht4 receptor agonistic activity |
03/10/2005 | WO2005021536A2 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors |
03/10/2005 | WO2005021519A2 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases |
03/10/2005 | US20050054680 Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides |
03/10/2005 | US20050054664 Anticholinergics, processes for preparing them and pharmaceutical composition containing them |
03/10/2005 | CA2537123A1 New compounds |
03/10/2005 | CA2533175A1 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases |
03/09/2005 | EP1511710A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer s disease, type 2 diabetes, and parkinson s disease |
03/09/2005 | CN1192019C Cyclic amine derivatives |
03/01/2005 | US6861425 Benzimidazole compounds as ORL1-receptor agonists |
02/24/2005 | US20050043308 Process for total synthesis of ecteinascidins and intermediates therefor |
02/24/2005 | US20050042176 Medicaments for inhalation comprising a novel anticholinergic and a steroid |
02/24/2005 | CA2743534A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
02/23/2005 | CN1585772A Chemokine receptor antagonists and methods of use thereof |
02/23/2005 | CN1190435C Process for preparation of 8-azabicyclo [3.2.1] Octane derivatives |
02/17/2005 | WO2005014578A1 Phenylsulfonyl compounds as antipsychotic agents |
02/17/2005 | WO2005013999A1 Medicaments for inhalation comprising steroids and a novel anticholinergic |
02/17/2005 | US20050038252 scopine/tropenol di-(2-furyl)-glycolate methobromide, used for treating asthma, chronic obstructive pulmonary disease, vagally induced sinus bradycardia, heart rhythm disorders, spasms in the gastrointestinal and urogenital systems, or menstrual pain |
02/16/2005 | EP1506205A2 Novel azacyclic ethynyl derivatives |
02/16/2005 | CN1582288A Heteroaryl derivatives as superior ligands for nociceptin receptor ORL-1 |
02/10/2005 | WO2005011694A1 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane tartrate salts |
02/10/2005 | WO2004101562A3 Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors |
02/10/2005 | WO2004054507A3 Indolizine compounds |
02/10/2005 | CA2534295A1 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane tartrate salts |
02/08/2005 | US6852728 Anticholinergics, processes for preparing them, and pharmaceutical compositions containing them |
02/03/2005 | WO2005009440A1 Muscarinic acetylcholine receptor antagonists |
02/03/2005 | WO2005009439A1 Muscarinic acetylcholine receptor antagonists |
02/03/2005 | WO2005009362A2 Muscarinic acetylcholine receptor antagonists |
02/03/2005 | WO2004054581A3 Cyclohexyl compounds as ccr5 antagonists |
02/03/2005 | CA2532433A1 Muscarinic acetylcholine receptor antagonists |
02/03/2005 | CA2532379A1 Muscarinic acetylcholine receptor antagonists |
02/03/2005 | CA2532375A1 Muscarinic acetylcholine receptor antagonists |
02/02/2005 | EP1501794A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors |
02/01/2005 | US6849621 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
01/27/2005 | WO2005007134A1 Powdery formulations for inhalation, containing a novel anticholinergic agent |
01/27/2005 | US20050020622 Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments |